Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00682825 · ClinicalTrials.gov registry record · Phase 4
Study Evaluating Whether the Bispectral Index Prevents Patients at Higher Risk From Being Awake During Surgery and Anesthesia
A Phase 4 study of Explicit Recall of Intra-Operative Events, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- Phase 4
- Development phase
- 6,000
- Enrollment target
- 3
- Study locations
NCT00682825 is a Phase 4 study of Explicit Recall of Intra-Operative Events that has completed, run by Washington University School of Medicine. The registered enrollment target is 6,000 participants. The trial reports 3 study locations across 3 states.
The verdict
NCT00682825, a Phase 4 study of Explicit Recall of Intra-Operative Events, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 6,000 participants
- Enrollment target
- 3
- Study locations
Study Summary
The overall purpose of this study is to see if a Bispectral Index (BIS) monitor, a Food and Drug Administration (FDA) approved brain monitoring device, will help to reduce the risk of patients remembering being awake during surgery. The BIS monitor may be able to measure how asleep a patient is during surgery. Using the BIS monitor to guide anesthesia will be compared with using the concentration of anesthetic gas to guide anesthesia.
Conditions Studied
Interventions
- BEHAVIORAL Bispectral index protocol
- BEHAVIORAL End tidal anesthetic gas-guided
Study Locations (3)
Illinois
- University of Chicago - Chicago
Missouri
- Washington University - St Louis
Manitoba
- University of Manitoba - Winnipeg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6,000 participants |
| Start Date | 2008-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00682825
The ClinicalTrials.gov registry entry for NCT00682825 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 6,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Explicit Recall of Intra-Operative Events appearing as the primary indexed condition, and to 2 interventions - of which Bispectral index protocol is the first listed.
NCT00682825 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Illinois, Missouri, Manitoba.
Frequently Asked Questions
What is clinical trial NCT00682825 about?
NCT00682825 is a clinical study titled "Study Evaluating Whether the Bispectral Index Prevents Patients at Higher Risk From Being Awake During Surgery and Anesthesia". The overall purpose of this study is to see if a Bispectral Index (BIS) monitor, a Food and Drug Administration (FDA) approved brain monitoring device, will help to reduce the risk of patients remembering being awake during surgery. The BIS monitor may be able to measure how asleep a patient is duri...
What is the current status of trial NCT00682825?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 6,000 participants. The study started on 2008-03.
What conditions does trial NCT00682825 study?
This clinical trial studies the following conditions: Explicit Recall of Intra-Operative Events.
What interventions are being tested in trial NCT00682825?
The interventions under investigation include: Bispectral index protocol (BEHAVIORAL), End tidal anesthetic gas-guided (BEHAVIORAL).
Who is sponsoring clinical trial NCT00682825?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00682825 being conducted?
This trial has 3 study locations across Illinois, Missouri, Manitoba. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.